Literature DB >> 12849896

Appropriateness in programs for continuous quality improvement in clinical laboratories.

Mario Plebani1.   

Abstract

BACKGROUND: External reviews and the accreditation of medical laboratories involve more than the mere assessment of conformance with standards for organisational processes. The new approaches to quality improvement suggest that, rather than using inspection to correct unusual errors, there should be more emphasis on improving the processes of health care to ensure that desired outcomes are produced. Appropriateness plays a key role in programs for quality improvement.
METHODS: Appropriateness in laboratory medicine can be assessed, and improved, through the governance of the entire testing process. This begins with test selection, proceeds through valuable pre-, intra- and post-analytical procedures, and concludes by assuring the correct interpretation and utilization of laboratory information.
RESULTS: The International Standard, specifically developed for medical laboratories (ISO 15189) recognizes the value of appropriate interpretation and advisory services, although it does not specify requirements for assessing appropriateness, requesting tests and interpreting results. The effectiveness of clinical laboratories can be assessed by using surrogate markers, which indicate physicians' satisfaction, and clinical audits. Effectiveness is also enhanced by stressing the importance of the technical and professional competence of evaluators.
CONCLUSIONS: Inappropriate laboratory utilization unjustifiably increases health care costs, can harm patients and perpetuates the vision of laboratory testing as a commodity. Improvement in laboratory appropriateness can be achieved by seeking a better relationship with physicians and by stressing the role of laboratory specialists in providing clinical advice for the selection of laboratory tests, and the interpretation and utilization of their results, thus leading to more satisfactory clinical outcomes.

Entities:  

Mesh:

Year:  2003        PMID: 12849896     DOI: 10.1016/s0009-8981(03)00177-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

Review 1.  Autoimmune diagnostics: the technology, the strategy and the clinical governance.

Authors:  Nicola Bizzaro; Renato Tozzoli; Danilo Villalta
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 2.  Factors affecting hemoglobin measurement.

Authors:  Lauren Berkow
Journal:  J Clin Monit Comput       Date:  2013-03-26       Impact factor: 2.502

3.  Evaluation of Preanalytical Quality Indicators by Six Sigma and Pareto`s Principle.

Authors:  Sweta Kulkarni; R Ramesh; A R Srinivasan; C R Wilma Delphine Silvia
Journal:  Indian J Clin Biochem       Date:  2017-04-21

Review 4.  Managing the pre- and post-analytical phases of the total testing process.

Authors:  Robert Hawkins
Journal:  Ann Lab Med       Date:  2011-12-20       Impact factor: 3.464

5.  Pre-analytical requirements.

Authors:  John H Livesey; M Jane Ellis; Margaret J Evans
Journal:  Clin Biochem Rev       Date:  2008-08

6.  Longitudinal trends in laboratory test utilization at a large tertiary care university hospital in Sweden.

Authors:  Mirja Mindemark; Anders Larsson
Journal:  Ups J Med Sci       Date:  2010-11-11       Impact factor: 2.384

7.  Clinical biochemistry laboratory rejection rates due to various types of preanalytical errors.

Authors:  Aysenur Atay; Leyla Demir; Serap Cuhadar; Gulcan Saglam; Hulya Unal; Saliha Aksun; Banu Arslan; Asuman Ozkan; Recep Sutcu
Journal:  Biochem Med (Zagreb)       Date:  2014-10-15       Impact factor: 2.313

8.  Working towards accreditation by the International Standards Organization 15189 Standard: how to validate an in-house developed method an example of lead determination in whole blood by electrothermal atomic absorption spectrometry.

Authors:  Carine Garcia Hejl; Jose Manuel Ramirez; Philippe Vest; Denis Chianea; Christophe Renard
Journal:  Ann Lab Med       Date:  2014-08-21       Impact factor: 3.464

Review 9.  The state of point-of-care testing: a European perspective.

Authors:  Anders Larsson; Roman Greig-Pylypczuk; Albert Huisman
Journal:  Ups J Med Sci       Date:  2015-01-26       Impact factor: 2.384

10.  Analysis of factors influencing the generation of unqualified clinical samples and measures to prevent this generation.

Authors:  Xiaofei Lai; Ping Yang; Yuhong Zhang; Ju Cao; Liping Zhang
Journal:  Ann Lab Med       Date:  2012-04-18       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.